Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
155,850,778
-
Share change
-
-3,576,650
-
Total reported value
-
$2,963,320,040
-
Put/Call ratio
-
22%
-
Price per share
-
$19.09
-
Number of holders
-
235
-
Value change
-
-$77,138,233
-
Number of buys
-
121
-
Number of sells
-
112
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2021
As of 31 Dec 2021,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
155,850,778 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, BlackRock Inc., ARK Investment Management LLC, ORBIMED ADVISORS LLC, FARALLON CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, and STATE STREET CORP.
This page lists
235
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.